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Abstract
Background: Although it is believed that fish ω-3 fatty acids may decrease breast cancer risk,
epidemiological evidence has been inconclusive. This study examined the association between fish
and fish ω-3 fatty acids intake with the risk of breast cancer in a case-control study of Korean
women.
Methods: We recruited 358 incident breast cancer patients and 360 controls with no history of
malignant neoplasm from the National Cancer Center Hospital between July 2007 and April 2008.
The study participants were given a 103-item food intake frequency questionnaire to determine
their dietary consumption of fish (fatty and lean fish) and ω-3 fatty acids derived from fish
(eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA)).
Results: Using a multivariate logistic regression model, high intake of fatty fish was associated with
a reduced risk for breast cancer in both pre- and postmenopausal women (OR [95% CI] for highest
vs. lowest intake quartiles, p for trend: 0.19 [0.08 to 0.45], p < 0.001 for premenopausal women,
0.27 [0.11 to 0.66], p = 0.005 for postmenopausal women). Similarly, reductions in breast cancer
risk were observed among postmenopausal subjects who consumed more than 0.101 g of EPA (OR
[95% CI]: 0.38 [0.15 to 0.96]) and 0.213 g of DHA (OR [95% CI]: 0.32 [0.13 to 0.82]) from fish per
day compared to the reference group who consumed less than 0.014 g of EPA and 0.037 g of DHA
per day. Among premenopausal women, there was a significant reduction in breast cancer risk for
the highest intake quartiles of ω-3 fatty acids (ORs [95% CI]: 0.46 [0.22 to 0.96]), compared to the
reference group who consumed the lowest quartile of intake.
Conclusion: These results suggest that high consumption of fatty fish is associated with a reduced
risk for breast cancer, and that the intake of ω-3 fatty acids from fish is inversely associated with
postmenopausal breast cancer risk.
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Background
Breast cancer is one of the most prevalent cancers in the
world including South Korea [1,2]. The second report by
the World Cancer Research Fund and the American Insti-
tute for Cancer Research indicates that food and nutrition
may affect the status of hormones that can modify breast
cancer risk [3]. Among the dietary factors, there has been
mixed evidence regarding the impact of fish and ω-3 fatty
acid intake on breast cancer risk. Animal studies have
demonstrated that a diet containing α-linolenic acid-rich
linseed oil is very effective in arresting mammary tumor
progression [4], and fish oil or a diet containing EPA or
DHA can suppress tumor growth and inhibit metastases
formation [5,6]. Ecological studies have suggested inverse
relations between fish and fish ω-3 fatty acid intake and
breast cancer risk [7,8]. However, results from case-con-
trol or cohort studies varies depending on the study
design [9] and study populations [10-13]. Most studies on
fish consumption and breast cancer are limited by their
lack of distinction between fatty (blue) and lean (white)
fish. The association between fatty and lean fish consump-
tion and breast cancer risk was examined in a large nation-
wide case-control study in Sweden [14], though a weak,
inverse association of dietary fish intake and breast cancer
was detected (not significant), no clear difference was
observed based on the type of fish. In contrast, the Norwe-
gian Women and Cancer Study [15] found no association
between salmon consumption and breast cancer risk. A
recent large multi-center European Prospective Investiga-
tion into Cancer and Nutrition (EPIC) study suggested
that there was no association between total, lean, or fatty
fish intake with breast cancer risk. The results were not
affected by menopausal status, although there was a posi-
tive association in the highest quintile for fatty fish with
no statistically significant test for trend [10]. Stipp et al.
[16] found a positive association between total fish intake
and breast cancer risk, but the type of fish or preparation
method played no significant role. The authors suggested
that other factors associated with fish intake, apart from
ω-3 fatty acids, might be responsible for this association.
This study investigated the association between fish intake
and the incidence of breast cancer in Korean women. It
was designed to investigate the possible effects of ω-3 fatty
acid consumption using a case-control breast cancer-study
design. We evaluated per capita energy and nutrient intake
with particular emphasis on the intake of total fish (cate-
gorized into fatty and lean fish) and fish ω-3 fatty acids
(total ω-3 fatty acids, eicosapentaenoic acid (EPA), and
docosahexaenoic acid (DHA)).
Methods
Study subjects
Eligible breast cancer patients were enrolled at the Center
for Breast Cancer, National Cancer Center Hospital, Korea
between July 2007 and September 2008. Among 424 inci-
dent breast cancer patients aged 25 to 77 years old admit-
ted for surgery, 398 patients agreed to participate in the
study. After patients with a previous history of cancer or
an inability to participate in the interview were excluded,
362 patients were eligible for enrollment. During the
same period, the control group was enrolled at the Center
for Early Detection and Prevention at the same hospital.
Visitors to the Center for Early Detection and Prevention
received health check-ups, including screening for five
major cancers (stomach, colorectum, liver, breast, and
uterine cervix) based on their eligibility for the National
Cancer Screening Program [17]. Among 2,503 women
who were contacted by the interviewers, 1,489 agreed to
participate in the study. After excluding women with a his-
tory of malignant neoplasm or benign breast diseases and
those that failed to complete the FFQ, 617 were eligible
for inclusion. Participants who reported an implausible
daily energy intake (≤ 600 kcal or ≥ 3500 kcal) were
excluded (5 cases and 2 controls), and the controls were
frequency-matched to cases using a 5-year age distribu-
tion. Final analysis was done for 358 cases and 360 con-
trols. Study protocols and consent forms were approved
by the institutional review board of the National Cancer
Center Hospital (IRB protocol number NCCNCS 07-083),
and all subjects provided informed consent for study par-
ticipation.
Data collection
A trained dietitian collected information on participant
demographics and lifestyle factors (e.g., smoking habits,
alcohol intake, and physical activity), using a structured
questionnaire. Reproductive information was also col-
lected (e.g., age at menarche, menopause status, age at
menopause, menopausal status, postmenopausal hor-
mone use, and parity). Smoking history was categorized
as none, past, or current. A food frequency questionnaire
(FFQ) was developed and validated to determine regular
dietary intake. The reliability and validity of the FFQ have
been previously reported [18]. Subjects were presented
with a list of 103 food items and queried on the average
frequency and the typical portion sizes of the specific
foods eaten during the previous year. The average daily
nutrient intake for each subject was measured by adding
the intake amount and associated nutrient content per
100 g for each of the 103 foods. This value was converted
to a daily nutrient intake using the scales for consumption
frequency (i.e., never or rarely, once a month, two or three
times a month, once or twice a week, three or four times a
week, five or six times a week, once a day, twice a day, and
three times a day) and portion size (i.e., small, medium,
and large) included in the food frequency questionnaire.
Eight fish items, covering 6 fatty fishes and 17 lean fishes,
were included in the FFQ. The eight items were raw fish,
blue (fatty) fish, hair tail, eel, yellow croaker/sea bream/BMC Cancer 2009, 9:216 http://www.biomedcentral.com/1471-2407/9/216
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flat fish, Alaskan pollack/Alaskan pollack (frozen)/
Alaskan pollack (dried), anchovy/anchovy (marinated),
and tuna (canned). We classified the types of fishes con-
sumed (fatty and lean fish) to calculate the estimated
amount of fatty acid consumption (EPA and DHA) and
determine the effect of each fatty acid on breast cancer
risk. The validity of the FFQ used in the current study has
been tested using the 3-day dietary record as a gold stand-
ard in a total of 202 persons. The de-attenuation correla-
tion coefficients, percent agreements of the same plus
adjacent quartile categories, and percent gross misclassifi-
cation were 0.491, 75.2% and 8.3% for total ε-3 fatty
acids, respectively, 0.482, 70.6%, and 10.1% for EPA,
respectively, and 0.549, 74.3%, and 5.5% for DHA,
respectively.
Statistical analysis
Alcohol consumption was categorized as either have or
have not consumed alcohol. Physical activity was meas-
ured using the short form of the International Physical
Activity Questionnaire (IPAQ) and summarized into met-
abolic equivalent (MET) units (minutes/week). Odds
ratios (ORs) and 95% confidence intervals (CIs) were cal-
culated, and the significance level was set at 5% for all sta-
tistical tests. The Chi-square and t-tests were used to
compare characteristics between cases and controls. The
consumed amounts of energy, fishes, and ω-3 fatty acids
of cases and controls were compared using the t-test.
Intake quartiles for fish and ω-3 fatty acids were catego-
rized based on the intake values of control group. The SAS
9.1 (SAS Institute Inc., Cary, NC) LOGISTIC procedure
was utilized to calculate odds ratios and their confidence
intervals for fish and ω-3 fatty acids intake quartiles on
breast cancer risk. Data were stratified by menopausal sta-
tus. Multivariate models were adjusted for age, body mass
index (BMI), family history of breast cancer, dietary sup-
plement use, education level, occupation, alcohol con-
sumption, smoking status, physical activity, age at
menarche, parity, total energy intake, postmenopausal
hormone use, menopausal status, and age at menopause.
Especially, energy-adjusted nutrient intakes were com-
puted as the residuals from the regression model with
total caloric intake as the independent variable and abso-
lute nutrient intake as the dependent variable [19]. To test
for linear trends across fish and ω-3 fatty acids quartiles,
the median intake of each quartile category was used as a
continuous variable to test for trends.
Results
The general characteristics of the study subjects are pre-
sented in Table 1. The mean ages of cases and controls
were 48.3 and 47.9 years of ages, respectively, which were
not statistically different. There were significant differ-
ences between the cases and controls for BMI (p = 0.003),
dietary supplement use (p = 0.001), education (p <
0.001), occupation (p = 0.012), age at menarche (p <
0.001), and postmenopausal hormone use (p < 0.001).
The amounts of fish and fish ω-3 fatty acids consumed by
cases and controls are presented in Table 2. In general, the
cases had significantly lower total fish (p = 0.012) and
fatty fish intake (p < 0.001), but a higher energy intake (p
= 0.032). With regard to menopause status, premenopau-
sal breast cancer patients had a lower intake of fatty fish
than controls (p < 0.001). Postmenopausal breast cancer
patients consumed lower amounts of total fish (p =
0.022), fatty fish (p < 0.001), ω-3 fatty acids (p < 0.001),
EPA (p < 0.001), and DHA (p < 0.001), but had a higher
energy intake than controls (p = 0.039).
Table 3 shows the risk of breast cancer in relation to fish
intake in both age-adjusted and multivariate-adjusted
models. After adjusting for confounding variables in the
multivariate logistic regression models, there was a pro-
tective effect of fatty fish intake for all study subjects in the
highest quartile (OR [95% CI], p for trend: 0.23 [0.13 to
0.42], p < 0.001) compared to the lowest. The protective
effect of fatty fish intake was observed in both pre- and
postmenopausal women.
Table 4 presents the odds ratios of breast cancer risk with
regard to ω-3 fatty acid intake. Among premenopausal
women, there was a significant reduction in breast cancer
risk for the highest intake quartiles of ω-3 fatty acids (ORs
[95% CI]: 0.46 [0.22 to 0.96], compared to the reference
group who consumed the lowest quartile of intake. How-
ever, there was no significant association between EPA or
DHA intake and breast cancer risk in premenopausal
women. After adjusting for confounding variables in the
multivariate logistic regression models, postmenopausal
subjects consuming more than 0.101 g of EPA and 0.213
g of DHA from fish per day showed a 62% and 68%
decreased breast cancer risk compared to the reference
group (who consumed less than 0.014 g of EPA and 0.037
g of DHA per day), respectively. In contrast, there was no
statistically significant difference in any quartile category
compared to the lowest intake of ω-3 fatty acids, although
p for trend was marginally significant (p = 0.068).
Discussion
The results of studies investigating the association
between ω-3 fatty acids and breast cancer risk vary accord-
ing to the study design. A meta-analysis of biomarker
studies based on three cohort and seven case-control stud-
ies found a significant protective effect for total ω-3
PUFAs, but only an inverse association with borderline
significance for α-linolenic acid in case-control studies.
The authors suggested that the findings of cohort studies
fit well with the hypotheses of experimental animal stud-
ies [9]. However, according to a recent systematic review,
one study showed a significantly increased risk for breastBMC Cancer 2009, 9:216 http://www.biomedcentral.com/1471-2407/9/216
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Table 1: General Characteristics of Study Subjects
Variables Control (n = 360) Case (n = 358) P
Age (years)a 47.9 ± 8.7 48.3 ± 8.6 0.633
Body mass index (kg/m2)
< 18.5 8(2.2) 16(4.5) 0.003
18.5- < 23 150(42.4) 153(42.7)
23- < 25 121(34.2) 85(23.7)
≥ 25 75(21.2) 104(29.1)
Family history (yes) 12(3.6) 17(4.8) 0.429
Supplement use (yes) 167(67.1) 194(54.3) 0.001
Marital status
Married 288(83.0) 289(80.7) 0.588
Single 14(4.0) 20(5.6)
Divorced, Widowed, Other 45(13.0) 49(13.7)
Education
≤ Elementary school 21(6.1) 59(16.5) < 0.001
Middle school 17(4.9) 44(12.3)
High school 176(51.2) 174(48.6)
≥ College 130(37.8) 81(22.6)
Occupation
Housewife 212(61.1) 217(60.6) 0.012
Profession, Office worker 75(21.6) 54(15.1)
Sales, Service 43(12.4) 51(14.3)
Agriculture, Laborer, Unemployed, Other 17(4.9) 36(10.0)
Smoking status
Nonsmoker 305(93.3) 318(89.1) 0.066
Ex-smoker 12(3.7) 28(7.8)
Current smoker 10(3.0) 11(3.1)
Alcohol consumption (g/day)
0 175(56.6) 190(53.1) 0.144
0< ≡ 14.9 119(38.5) 137(38.2)
> 15 15(4.9) 31(8.7)
Physical activityb (Met-min/week)
≤ 396 77(22.9) 59(16.6) 0.076
396-<1272 91(27.0) 114(32.0)
1272-<2772 81(24.0) 101(28.4)
≥ 2772 88(26.1) 82(23.0)
Age at menarche (years)
≤ 13 97(28.9) 91(25.4) < 0.001
14 74(22.0) 97(27.1)
15 86(25.6) 53(14.8)
≥ 16 79(23.5) 117(32.7)
Menopausal status
No 196(54.4) 210(58.7) 0.254
Yes 164(45.6) 148(41.3)
Age at menopausec (years)
< 46 37(26.6) 43(29.5) 0.697
46-<49 35(25.2) 31(21.2)
49-<52 39(28.1) 47(32.2)
≥ 52 28(20.1) 25(17.1)
Type of menopausec
Natural 109(75.2) 98(66.7) 0.109
Surgery, Other 36(21.8) 49(33.3)
Postmenopausal hormone usec
Never 88(62.0) 115(80.4) < 0.001
Ever 54(38.0) 28(19.6)
Parity
No 46(12.8) 31(8.7) 0.074
Yes 314(87.2) 327(91.3)
n (%) or mean ± SD
a mean ± SD, b Metabolic equivalent units (METs) are multiples of the resting metabolic rate and calculated using the short form (version 2.0, April 
2004) of the International Physical Activity Questionnaire (IPAQ), c postmenopausal women.BMC Cancer 2009, 9:216 http://www.biomedcentral.com/1471-2407/9/216
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cancer, three studies showed a decreased risk, and seven
studies failed to show a significant association with ω-3
fatty acids intake [20]. A study of women from New York
City found no apparent association between fish intake
and breast cancer risk [12,14,21]. Consistent with this, a
large-scale EPIC study [10], and studies conducted in Nor-
way [22] and Sweden [23] found no apparent evidence for
an association between fish intake and breast cancer risk.
Holmes et al. reported a 9% increase in risk with a 0.1%
increase in energy from ω-3 fatty acids in the Nurses'
Health Study [24].
In addition to study design, ethnic groups have also
responded differently in these studies. For instance, a Jap-
anese population demonstrated a significant decrease in
postmenopausal breast cancer risk with increased fish
intake [25], and breast cancer risk was inversely associated
with erythrocyte compositions of EPA (OR, 0.27; 95% CI,
0.14–0.53 for the highest to the lowest tertile; p for trend
< 0.001), DHA (OR, 0.06; 95% CI, 0.02–0.16; p for trend
< 0.001), and ω-3 PUFAs (OR, 0.11; 95% CI, 0.05–0.24; p
for trend < 0.001) as biomarkers [26]. A similar trend was
found in another Japanese study performed by Wakai et
al[13], which detected a significant decrease in breast can-
cer risk in the highest quartile of fish fat and long-chain ω-
3 fatty acids intake compared with the lowest; the relative
risks were 0.56 (95% CI: 0.33–0.94) and 0.50 (95% CI:
0.30–0.85), respectively. The Singapore Chinese Healthy
Study demonstrated that high levels of dietary ω-3 fatty
acids from fish/shellfish were significantly associated with
a reduced risk for breast cancer [11]. Compared to the
lowest quartile of intake, individuals in the top three quar-
tiles exhibited a 26% reduction in risk. In ecological stud-
ies in the Netherlands [7] and Canada [8], there was an
increase in consumption of fish and fish ω-3 PUFAs that
may contribute to a lower breast cancer risk. A study of
Norwegian women found an inverse relationship
between breast cancer risk and consumption of poached
fish, although there was no association with overall fish
intake [27]. Additionally, in the UK, fish oil consumption
has been associated with protection against breast car-
cinogenesis [28,29]. A postmenopausal study conducted
in the US found a significant inverse association between
fish intake (canned, fried, fresh, and shellfish) and breast
cancer risk [30].
Many factors may contribute to these discrepant findings
in various regions, including sample size, adjustment for
potentially confounding variables, the detail and quality
of the dietary assessment, unmeasured changes in diet
over time, and the stage of cancer at diagnosis [31]. Alter-
natively, the study discrepancies could also be explained
by other two possibilities, either differences in the range
of fish intake or interactions between ω-3 fatty acids and
antioxidant components in the diet [32]. For example,
fish consumption in Japan and Korea is much higher than
in the United States [33]. The mean daily consumption of
24.1 g of total fish identified by this study, consists of
2.3% of total daily energy intake, but the US population
consumed only 0.74% of their total energy from fish [33].
The proportion was 6.21% in the Japanese population
[33]. It is also possible that low variability in fish or ω-3
fatty acids intake in each individual or non-differential
misclassification of estimated ω-3 fatty acid intake played
a role in these results [34]. Alternatively, findings from
animal studies have suggested that the strength of the
association with marine ω-3 fatty acids may be reduced in
the presence of high antioxidant intake, which has been
Table 2: Comparison of food and energy intake of the study subjects
Total Premenopausal women Postmenopausal women
Control Case P Control Case p Control Case P
(n = 360) (n = 358) (n = 196) (n = 210) (n = 164) (n = 148)
Total fish 
(g/day)
24.1 ± 21.1/
17.5
21.8 ± 21.3/
15.5
0.012 22.9 ± 18.1/
18.2
21.7 ± 21.1/
14.8
0.214 25.6 ± 24.1/
17.1
22.0 ± 21.8/
16.2
0.022
Lean fish 12.0 ± 11.2/
8.5
14.1 ± 14.9/
9.2
0.916 10.6 ± 8.5/8.3 13.4 ± 14.1/
8.5
0.494 13.6 ± 13.6/
9.4
15.1 ± 16.1/
10.5
0.637
Fatty fish 12.1 ± 13.4/
8.1
7.6 ± 9.7/4.5 < 0.001 12.3 ± 13.1/
8.7
8.2 ± 10.3/5.0 < 0.001 11.9 ± 13.9/
6.3
6.8 ± 8.8/3.6 < 0.001
ω-3 fatty 
acid (g/day)
0.228 ± 0.278/
0.143
0.168 ± 0.227/
0.090
< 0.001 0.216 ± 0.294/
0.128
0.179 ± 0.244/
0.098
0.089 0.242 ± 0.259/
0.157
0.152 ± 0.201/
0.079
< 0.001
EPA
(20:5n-3)
0.085 ± 0.147/
0.041
0.054 ± 0.089/
0.025
< 0.001 0.083 ± 0.172/
0.035
0.057 ± 0.098/
0.027
0.017 0.089 ± 0.111/
0.044
0.050 ± 0.075/
0.022
< 0.001
DHA
(22:6n-3)
0.174 ± 0.261/
0.092
0.115 ± 0.174/
0.056
< 0.001 0.166 ± 0.296/
0.082
0.123 ± 0.192/
0.061
0.084 0.184 ± 0.213/
0.105
0.104 ± 0.146/
0.051
< 0.001
Energy 
(kcal/day)
1752.5 ± 
548.5
1813.8 ± 
492.9
0.032 1797.6 ± 
574.9
1811.1 ± 
460.8
0.353 1698.5 ± 
511.6
1817.8 ± 
536.8
0.039
Data are presented as mean ± standard deviation/median.
EPA: Eicosapentaenoic acid, DHA: Docosahexaenoic acidB
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Table 3: Odds ratios of breast cancer risk according to level of fish intake
Total Premenopausal women Postmenopausal women
Control (n) Case (n) Age 
adjusted 
Odds ratio
Multivariate 
Odds ratioa
Control (n) Case (n) Age 
adjusted 
Odds ratio
Multivariate 
Odds ratiob
Control (n) Case (n) Age 
adjusted 
Odds ratio
Multivariate 
Odds ratioc
Total fish 
(g/day)
< 9.99 90 122 1.00 
(referent)
1.00 
(referent)
47 70 1.00 
(referent)
1.00 
(referent)
43 52 1.00 
(referent)
1.00 
(referent)
9.99-<17.51 90 80 0.65
(0.43–0.98)
0.64
(0.38–1.07)
49 52 0.69
(0.40–1.19)
0.57
(0.27–1.19)
41 28 0.57
(0.30–1.08)
0.55
(0.26–1.19)
17.51-<33.70 90 80 0.65
(0.43–0.98)
0.57
(0.34–0.95)
56 44 0.52
(0.30–0.90)
0.38
(0.18–0.78)
34 36 0.89
(0.48–1.67)
1.02
(0.47–2.22)
≥ 33.70 90 76 0.62
(0.41–0.93)
0.55
(0.32–0.96)
44 44 0.65
(0.37–1.14)
0.49
(0.22–1.10)
46 32 0.59
(0.32–1.09)
0.62
(0.28–1.39)
P for trend 0.054 0.063 0.157 0.094 0.205 0.475
Lean fish (g/day)
< 4.63 90 98 1.00 
(referent)
1.00 
(referent)
52 56 1.00 
(referent)
1.00 
(referent)
38 42 1.00 
(referent)
1.00 
(referent)
4.63-<8.53 90 70 0.71
(0.46–1.08)
0.74
(0.43–1.26)
49 45 0.84
(0.48–1.46)
0.86
(0.42–1.78)
41 25 0.53
(0.27–1.04)
0.43
(0.19–0.98)
8.53-<15.27 89 70 0.72
(0.47–1.10)
0.61
(0.36–1.04)
52 45 0.78
(0.45–1.36)
0.60
(0.29–1.22)
37 25 0.62
(0.31–1.22)
0.50
(0.22–1.16)
≥ 15.27 91 120 1.20
(0.81–1.79)
1.21
(0.72–2.04)
43 64 1.34
(0.78–2.32)
1.22
(0.58–2.57)
48 56 1.07
(0.59–1.92)
1.02
(0.47–2.21)
P for trend 0.102 0.236 0.181 0.551 0.286 0.328
Fatty fish (g/day)
< 3.42 90 147 1.00 
(referent)
1.00 
(referent)
44 63 1.00 
(referent)
1.00 
(referent)
44 69 1.00 
(referent)
1.00 
(referent)
3.42-<8.18 90 79 0.53
(0.36–0.80)
0.65
(0.39–1.08)
50 69 0.64
(0.37–1.16)
0.65
(0.31–1.35)
44 30 0.43
(0.24–0.79)
0.64
(0.31–1.31)
8.18-<15.39 90 91 0.61
(0.41–0.91)
0.54
(0.32–0.90)
52 55 0.62
(0.37–1.04)
0.50
(0.25–0.99)
34 32 0.61
(0.33–1.14)
0.64
(0.29–1.42)
≥ 15.39 90 41 0.27
(0.17–0.44)
0.23
(0.13–0.42)
50 23 0.29
(0.16–0.54)
0.19
(0.08–0.45)
42 17 0.26
(0.13–0.52)
0.27
(0.11–0.66)
P for trend < .001 < .001 < 0.001 < 0.001 < 0.001 0.005
a adjusted for age, BMI, family history of breast cancer, supplement use, education level, occupation, alcohol consumption, smoking status, physical activity, parity, total energy intake, menopausal 
status, age at menarche; b adjusted for age, BMI, family history of breast cancer, supplement use, education level, occupation, alcohol consumption, smoking status, physical activity, parity, total 
energy intake, age at menarche; c adjusted for age, BMI, family history of breast cancer, supplement use, education level, occupation, alcohol consumption, smoking status, physical activity, parity, 
total energy intake, postmenopausal hormone use, age at menarche. Energy-adjusted nutrient intakes were computed as the residuals from the regression model with total caloric intake as the 
independent variable and absolute nutrient intake as the dependent variable.B
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Table 4: Odds ratios of breast cancer risk according to ω-3 fatty acid intake level
Total Premenopausal women Postmenopausal women
Control (n) Case (n) Age 
adjusted 
Odds ratio
Multivariate 
Odds ratioa
Control (n) Case (n) Age 
adjusted 
Odds ratio
Multivariate 
Odds ratiob
Control (n) Case (n) Age 
adjusted 
Odds ratio
Multivariate 
Odds ratioc
ω-3 fatty acid 
(g/day)
< 0.059 90 134 1.00 
(referent)
1.00 
(referent)
47 73 1.00 
(referent)
1.00 
(referent)
43 61 1.00 
(referent)
1.00 
(referent)
0.059-<0.143 90 90 0.67
(0.45–1.00)
0.83
(0.50–1.37)
57 55 0.61
(0.36–1.03)
0.83
(0.42–1.64)
33 35 0.76
(0.41–1.41)
1.01
(0.48–2.15)
0.143-<0.296 90 76 0.56
(0.37–0.85)
0.74
(0.44–1.24)
46 46 0.62
(0.36–1.08)
0.83
(0.40–1.70)
44 30 0.49
(0.26–0.90)
0.76
(0.35–1.61)
≥ 0.296 90 58 0.43
(0.28–0.66)
0.47
(0.27–0.80)
46 36 0.49
(0.28–0.87)
0.46
(0.22–0.96)
44 22 0.35
(0.18–0.68)
0.51
(0.22–1.13)
P for trend < 0.001 0.004 0.037 0.040 0.001 0.068
EPA(20:5n-3) 
(g/day)
< 0.014 90 124 1.00 
(referent)
1.00 
(referent)
54 66 1.00 
(referent)
1.00 
(referent)
36 58 1.00 
(referent)
1.00 
(referent)
0.014-<0.041 95 103 0.79
(0.53–1.17)
0.90
(0.55–1.48)
53 63 0.96
(0.57–1.61)
1.11
(0.57–2.15)
42 40 0.61
(0.33–1.12)
0.81
(0.38–1.73)
0.041-<0.101 85 76 0.65
(0.43–0.98)
0.91
(0.54–1.55)
47 45 0.78
(0.45–1.35)
1.13
(0.54–2.33)
38 31 0.52
(0.27–0.98)
0.78
(0.35–1.74)
≥ 0.101 90 55 0.44
(0.28–0.68)
0.50
(0.28–0.91)
42 36 0.68
(0.38–1.22)
0.67
(0.30–1.50)
48 19 0.25
(0.12–0.49)
0.38
(0.15–0.96)
P for trend < 0.001 0.016 0.182 0.227 < 0.001 0.035
DHA(22:6n-3) 
(g/day)
< 0.037 90 132 1.00 
(referent)
1.00 
(referent)
52 72 1.00 
(referent)
1.00 
(referent)
38 60 1.00 
(referent)
1.00 
(referent)
0.037-<0.092 90 90 0.68
(0.46–1.01)
0.86
(0.52–1.43)
52 54 0.74
(0.44–1.26)
0.91
(0.46–1.78)
38 36 0.61
(0.33–1.14)
0.90
(0.42–1.95)
0.092-<0.213 90 86 0.65
(0.43–0.97)
0.77
(0.46–1.28)
48 49 0.72
(0.42–1.23)
0.93
(0.46–1.85)
42 37 0.56
(0.31–1.04)
0.81
(0.37–1.75)
≥ 0.213 90 50 0.37
(0.24–0.58)
0.44
(0.24–0.79)
44 35 0.56
(0.32–1.00)
0.54
(0.24–1.20)
46 15 0.21
(0.10–0.42)
0.32
(0.13–0.82)
P for trend < 0.001 0.004 0.075 0.118 < 0.001 0.010
a adjusted for age, BMI, family history of breast cancer, supplement use, education level, occupation, alcohol consumption, smoking status, physical activity, parity, total energy intake, menopausal 
status, age at menarche; b adjusted for age, BMI, family history of breast cancer, supplement use, education level, occupation, alcohol consumption, smoking status, physical activity, parity, total 
energy intake, age at menarche; c adjusted for age, BMI, family history of breast cancer, supplement use, education level, occupation, alcohol consumption, smoking status, physical activity, parity, 
total energy intake, postmenopausal hormone use, age at menarche. EPA: Eicosapentaenoic acid, DHA: Docosahexaenoic acid. Energy-adjusted nutrient intakes were computed as the residuals 
from the regression model with total caloric intake as the independent variable and absolute nutrient intake as the dependent variable.BMC Cancer 2009, 9:216 http://www.biomedcentral.com/1471-2407/9/216
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proposed to inhibit the formation of lipid peroxidation
products [35,36]. There are still more possible reasons for
these inconsistencies. Halogenated hydrocarbons, includ-
ing polychlorinated biphenyls and dichlorodiphynyl-
trichloroethane, or heavy metals that are concentrated in
fish may exert estrogenic effects that could predispose
women to breast cancer [16,37]. In addition, genetic back-
grounds, such as polymorphisms in glutathione S-trans-
ferase, may modify the effect of marine ω-3 fatty acids
[38]. We also can not exclude the possibility that incon-
sistent results between epidemiological studies are due to
measurement errors associated with dietary assessment, as
these are inherent in a retrospective study design [19].
However, it remains possible that other nutrients or
micronutrients in fish are partly responsible for the
inverse association [39,40].
A study of metastatic mouse mammary carcinoma dem-
onstrated that a diet containing α-linolenic acid-rich lin-
seed oil was very effective in arresting tumor progression
in mice [4]. In addition, tumor growth and metastases for-
mation were inhibited by diets including fish oil [5] or
EPA or DHA [6]. Larsson proposed several molecular
mechanisms for the potential effect of ω-3 PUFAs on car-
cinogenesis: 1) suppression of arachidonic acid-derived
eicosanoid biosynthesis, 2) influence on transcription fac-
tor activity, gene expression, and signal transduction, 3)
alteration of estrogen metabolism, 4) increased and
decreased production of free radicals and reactive oxygen
species, and 5) effect on insulin sensitivity and membrane
fluidity [34]. For example, EPA and DHA cause a concen-
tration-dependent inhibition of breast cancer cell growth
[41,42]. Another possible mechanism could involve inhi-
bition of cyclooxygenase and p21 gene expression and up-
regulation of p53 gene expression [43,44].
The present study demonstrated that there were signifi-
cantly different effects of ω-3 fatty acids from fish on
breast cancer risk in pre-and postmenopausal women.
Reasons for the stronger associations in postmenopausal
women are not yet clear. With respect to the etiologies of
pre- and postmenopausal breast cancer, several hypothe-
ses are possible [45,46]. The relationship between dietary
fat intake and breast cancer risk in premenopausal women
may differ from that in postmenopausal women. Adipos-
ity and reproductive factors act reversely on the sensitivity
of breast cancer tissue [46,47]. One study found that post-
menopausal patients had significantly lower levels of
DHA in breast adipose tissue compared to controls with
benign breast disease [48]. It is also plausible that diet has
a stronger impact on breast cancer risk during early adult
life than later in life [49]. Maillard et al. [50] and Bagga et
al. [51] confirmed that long-chain ω-3 fatty acids have a
beneficial effect in postmenopausal women, using breast
adipose tissue as a biomarker.
The present study is the first to explore the relationship
between fish and fish ω-3 fatty acid intake with breast can-
cer risk in a Korean population. The data were gathered in
a detailed face-to-face interview, which enabled the collec-
tion of comprehensive information on related lifestyle
factors, thus lessening the potential for misclassification
and measurement errors. In spite of such strengths, this
study also possesses some of the limitations usually inher-
ent to case-control study designs (i.e., selection and recall
biases). In particular, the control group was more likely to
be highly educated or a professional/office worker, which
suggests that participants enrolled from the cancer screen-
ing program may over-represent those with healthier hab-
its as opposed to their community-based counterparts.
Well-known menstrual risk factors for breast cancer, such
as early age at menarche, late age at menopause, or hor-
mone replacement therapy use, did not show definitive
associations in the current study population. However,
high body mass index and other hormone-related risk fac-
tors showed a positive association with breast cancer risk.
Cancer patients may differ from controls in their recall of
dietary habits. For this reason, the interviewer tried to col-
lect information as soon as possible after diagnosis, which
was typically right after surgery. In addition, a wide range
of potentially confounding factors, including demo-
graphic and lifestyle characteristics, still need to be con-
sidered. We were also constrained by our inability to
identify other sources of dietary ω-3 fatty acids. The addi-
tion of supplements may have enabled us to identify the
impact of total ω-3 fatty acids intake. Notably, this study
did not include information on fish species (cod, salmon,
mullet, etc.), preparation methods (frying, deep frying,
poaching, etc.), how long the fish was cooked, or how the
fish was consumed (with sauce, vegetable, salted, etc.).
These factors may help to elucidate the mechanism
whereby fish intake is associated with decreased breast
cancer risk. Moreover, further investigations into the die-
tary intake of halogenated hydrocarbons or heavy metals
and genetic factors will be important in clarifying the pre-
ventive effect of fish intake on breast cancer.
Conclusion
This investigation has identified fish and fish ω-3 fatty
acid intake as an important potential protective factor in
the nutritional etiology of breast cancer. Our results
revealed an inverse relation between breast cancer risk and
dietary intake of fatty fish and ω-3 fatty acids from fish.
These findings will provide the basis for further studies.
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